IMRN

0.89985.86%
AL

Aaron Laurita

Chief Financial Officer

Mr. Aaron Laurita is Chief Financial Officer of Radiopharm Theranostics Limited from April 2026. Mr. Laurita is Chief Financial Officer of Chimeric Therapeutics Limited. Mr. Laurita is Chief Financial Officer of Immuron Limited from February 9, 2026. Mr. Laurita holds a Bachelor of Business (Professional Accountancy) from RMIT University and is a qualified Chartered Accountant and a member of Chartered Accountants Australia and New Zealand.

Positions